On October 20, 2025, DLA Piper held a bootcamp for pre-IPO and growth-stage companies in the biotech and medtech industries in the firm’s New York office. Attended by nearly 100 individuals, the bootcamp covered topics including late-stage financings, paths for going public, financial preparedness, regulatory considerations, compliance issues, intellectual property (IP) strategies, and licensing and partnering agreements led by DLA Piper attorneys and leading industry advisors.
Source: DLA Piper Hosts Bootcamp for Biotech and Medtech Companies